Bon Natural Life Limited
BON · NASDAQ
3/31/2025 | 9/30/2024 | 3/31/2024 | 9/30/2023 | |
|---|---|---|---|---|
| Revenue | $8 | $14 | $10 | $15 |
| % Growth | -41.8% | 34.1% | -33.8% | – |
| Cost of Goods Sold | $6 | $10 | $7 | $11 |
| Gross Profit | $2 | $4 | $3 | $4 |
| % Margin | 24% | 30.3% | 29.1% | 26.8% |
| R&D Expenses | $0 | $1 | $1 | $0 |
| G&A Expenses | $0 | $1 | $2 | $1 |
| SG&A Expenses | $2 | $2 | $2 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $2 | $3 | $1 |
| Operating Income | $0 | $2 | $0 | $3 |
| % Margin | 3.6% | 13.1% | 0.8% | 19.1% |
| Other Income/Exp. Net | $0 | $0 | -$0 | $0 |
| Pre-Tax Income | $0 | $1 | $0 | $3 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | -$0 | $2 |
| % Margin | 2.1% | 3% | -0.1% | 16.1% |
| EPS | 0.56 | 0.23 | -0.008 | 2.64 |
| % Growth | 143.5% | 2,904.9% | -100.3% | – |
| EPS Diluted | 0.5 | 0.22 | -0.008 | 2.6 |
| Weighted Avg Shares Out | 0 | 2 | 1 | 1 |
| Weighted Avg Shares Out Dil | 0 | 2 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $0 | $1 | $1 |
| EBITDA | $1 | $1 | $1 | $4 |
| % Margin | 15.1% | 9.5% | 7.6% | 23.5% |